Home » Data backs Abbott Aveir dual-chamber leadless pacemaker
By Sean Whooley
Abbott (NYSE:ABT) today announced late-breaking results from a study of its Aveir dual-chamber (DR) i2i leadless pacemaker.
The data came from the company’s large-scale FDA investigational device exemption (IDE) study. It assesses Aveir DR, the world’s first dual-chamber leadless pacemaker for safety and performance. Abbott said the data suggests that Aveir DR could offer new benefits for those with slower-than-normal heart rhythms.
The company presented results at Heart Rhythm Society’s 44th annual meetings in New Orleans. The New England Journal of Medicinesimultaneously published the data. Abbott also provided this data to the FDA as part of its submission for approval of Aveir DR.
Aveir DR delivers electrical impulses directly to the heart muscle. This restores the normal heart rhythm. Unlike traditional pacemakers, the leadless devices go directly into the heart through a minimally invasive, catheter-based procedure. This eliminates the need for cardiac leads and a pulse generator under the skin.
Abbott said that, while many people require pacing and sensing in both the right atrium and right ventricle, currently available leadless pacing options have been limited to single-chamber ventricular devices. The company attributed this to the technological challenge of wireless synchronization for two leadless pacemakers.
In contrast, competitor Medtronic’s Micra AV is a single leadless pacemaker with several internal atrial sensing algorithms that detect cardiac movement. The Micra AV can adjust pacing in the ventricle to coordinate with the atrium, enabling it to provide “AV synchronous” pacing therapy to people with atrioventricular block.
Co-principal investigator Dr. Reinoud Knops said dual-chamber, leadless pacemakers have never been an option due to the challenges of wireless synchronization. Knops serves as a professor of medicine at Amsterdam University Medical Center, the Netherlands.
“Data from the AVEIR DR i2i study show that Abbott has designed a groundbreaking technology for seamless communication between two leadless pacemakers, and that AVEIR DR can deliver appropriate therapy safely, opening up a future treatment option for more people with abnormal heart rhythms,” Knops said.
About Aveir DR and the Abbott study
Abbott designed Aveir DR with a first-of-its-kind implant-to-implant (i2i) technology. It provides beat-to-beat communication and synchrony between the two leadless pacemakers. Unlike other leadless options, the system enables the two devices to communicate with one another. They can sense for delayed or missed heartbeats and pace the appropriate chamber of the heart.
The Aveir devices utilize specially designed attachment mechanisms that allow for the retrieval of pacemakers when necessary, too. In the study, physicians successfully implanted leadless pacemakers in the right atrium along with a leadless device in the right ventricle for the first time.
Abbott’s study analyzed primary safety and efficacy endpoints in the first 300 people enrolled. The study evaluated participants across 55 centers in the U.S., Canada and Europe through three months post-implant.
Results demonstrated a 98.3% implant success rate. The study achieved its safety endpoint evaluating freedom from device or procedure-related complications, too.
Abbott said more than 97% of people presented successful atrioventricular (AV) synchrony. This means the upper and lower chambers beat normally, despite different types of underlying slow heart rhythms. The average AV synchrony came in at 95% in each of the seven different posture and walking speeds. Abbott said this demonstrated that the system functions appropriately during everyday life activities.
“For the first time, the AVEIR DR i2i study has shown that a dual-chamber leadless pacing device is not only possible but can meet the rigors of everyday needs of pacing therapy,” said Randel Woodgrift, SVP of Abbott’s cardiac rhythm management business. “The results of the AVEIR DR study are a strong indicator that the AVEIR dual-chamber pacemakers can offer new options so that physicians can treat a broader group of people that need pacemaker therapies. ”
Read next: MassDevice recently spoke with Dr. Leonard Ganz about Abbott’s cardiac rhythm management efforts.
In case you missed it
- Analysts still high on Insulet despite Medtronic’s EOFlow buy, stock market reaction
- The top cardiac care innovation news at Heart Rhythm 2023
- FDA approves Zoll therapy for sleep apnea with MRI
- Boston Scientific won’t buy majority stake in M.I. Tech
- Convatec, Beta Bionics partner on iLet bionic pancreas
- HeartBeam wins AI-related patent for handheld vector ECG
- Medtronic stock down as growth projections underwhelm
- Medtronic to acquire wearable insulin patch maker EOFlow for $738M
- Fast Five: Boston Scientific adds 400 jobs in Ireland, ICU Medical recalls some infusion pump batteries
- ClearPoint Neuro enters drug delivery licensing deal with UCB
- Research supports brain-computer interface tech from Onward
- Artelon raises $20M for joint instability treatment
- Aerami presents positive data for inhaled pulmonary hypertension treatment
- Artivion gains FDA approval for PerClot, starts transfer to Baxter
- Stryker announces first completed cases with brain surgery guidance platform
- Abbott CardioMEMS sensor nearly halves heart failure hospitalizations, study says
- Masimo expands HEOS home monitoring platform
From Medical Design & Outsourcing
- Stratasys and Desktop Metal plan $1.8B merger
Stratasys (Nasdaq:SSYS) and Desktop Metal (NYSE:DM) plan to combine in a $1.8 billion all-stock transaction, the 3D printing companies said today. The companies estimate they will generate $1.1 billion in 2025 revenue after the merger and said they expect the additive manufacturing industry to grow to $100 billion by 2032. Stratasys and Desktop Metal both… […]
- What’s new in 3D printing: medical devices, research, innovation, automation and partnerships
3D printing is helping more patients than ever before through personalized medical devices, faster and cheaper prototyping and more affordable manufacturing. Recent developments include research into tissue and organ regeneration, lightning-fast responses to supply chain shortages, wearables that improve patient treatment, and major investments by device manufacturers. Here are some of the 3D printing advances… […]
- Times Microwave Systems launches XtendedFlex 045 micro-coaxial cable
NEWS RELEASE: Times Microwave Systems Introduces XtendedFlex 045 Micro-coaxial Cable New Addition to XtendedFlex™ Product Line Features Unrivaled Compactness and Flexibility in a Low Loss Construction for Precision Medical Devices and More WALLINGFORD, CT — Times Microwave Systems, the preeminent brand in innovative RF and microwave interconnect assemblies, cables, and connectors, has announced the release… […]
- Zimmer Biomet’s Ossis purchase expands reach for Bio-Gate
NEWS RELEASE: Bio-Gate and OSSIS expand into additional international markets with HyProtect™ Coatings on Compassionate Care implants. Stronger and expanded international market access of OSSIS after acquisition by Zimmer Biomet Increased awareness of HyProtect™ coatings Increased volume of HyProtect™ coated implants Nuremberg/Bremen – Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual… […]
- How device founders can find a buyer for their medtech
If you’re a medtech entrepreneur looking to sell your medical device business, Frank Jaskulke is a great contact to have in your network. He’s VP of intelligence at Medical Alley and the head of its Medical Alley Starts program, which offers resources and support for healthcare startups. His Minnesota-focused organization has worked with more than… […]
- 3D-printed wearable sweat sensor could advance home monitoring
Researchers at the University of Hawaiʻi at Mānoa College of Engineering say they developed a 3D-printed, wearable sweat sensor. Called the “sweatainer,” the device harnesses the power of additive manufacturing to enable a new type of wearable sweat sensor. The researchers say the small, wearable device — similar in size to a child’s sticker —… […]
- MedAccred joins The Irradiation Panel
NEWS RELEASE: MedAccred Program Joins Influential Irradiation Industry Association The MedAccred program has become a member of The Irradiation Panel, a renowned not-for-profit industry association representing global and diverse interests in radiation processing. The panel is comprised of suppliers and users of irradiated products and irradiation services, regulatory bodies, and consultants. Membership currently consists of… […]
- Mexico Ministry of Health updates rules and requirements for medical device classification
Ana Karen Hidalgo Rodríguez, Emergo Group Continuing with our updates over the recently released 5.0 edition of the Supplement of Medical Devices of the Mexican Pharmacopoeia (hereafter: Pharmacopoeia), we discuss the classification rules related to medical devices. Classification of medical devices based on their level of risk Appendix II of the Mexican Pharmacopoeia includes the… […]
- Times Microwave Systems unveils new micro-coaxial cable
Times Microwave Systems announced today that it unveiled its new TF-047 micro-coaxial cable for high performance and reliability in a compact footprint. Wallingford, Connecticut-based Times Microwave Systems designed TF-047 as a versatile SwaP-C solution with extensive connector capability. Its compact and flexible design enables easy routing in space-constrained areas. The cable features an overall diameter… […]
- These smart implant coatings watch for implant failure while killing bacteria
Researchers at the University of Illinois developed “smart” coatings for orthopedic implants that can monitor strain on the devices. These coatings monitor strain to provide early warnings of implant failures while killing infection-causing bacteria. They integrate flexible sensors with a nanostructured antibacterial surface. Researchers say they received inspiration for the surface from the wings of… […]
- Tips and red flags to help you select a medtech contract manufacturer
A few years ago, Vivasure Medical faced an emergency that “nearly shut our company down,” co-founder Gerard Brett said. “We picked a supplier in good faith — it looked like they had what it took to do the job for us,” he said. “We were working away at developing a part of our product, and… […]
About Sean Whooley
Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.